David Climie
Keine laufenden Positionen mehr
Karriereverlauf von David Climie
Ehemalige bekannte Positionen von David Climie
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Investor Relations Kontakt | 01.05.2011 | - |
Public Communications Contact | 01.05.2011 | - | |
PMC-SIERRA INC | Investor Relations Kontakt | 19.10.2011 | - |
Public Communications Contact | - | - | |
Vertrieb & Marketing | - | - |
Statistik
International
Vereinigte Staaten | 2 |
Kanada | 2 |
Operativ
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Sales & Marketing | 1 |
Sektoral
Electronic Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Microsemi Storage Solutions, Inc.
Microsemi Storage Solutions, Inc. SemiconductorsElectronic Technology Microsemi Storage Solutions, Inc. engages in the design, development, marketing, and support of semiconductor solutions by integrating its mixed-signal, software, and systems expertise through a network of offices in North America, Europe, and Asia. The company was founded by James V. Diller, Sr., Colin C. Harris, Brian Gerson, Gregory D. Aasen, Glenn Bindley, and Kevin Huscroft in 1984 and is headquartered in Sunnyvale, CA. | Electronic Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
- Börse
- Insiders
- David Climie
- Erfahrung